HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
173304.0,283256,2160-12-25 06:38:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
   8 hr post cath check unremarkable.
   Allergies:
   Sulfonamides
   Unknown;
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2160-12-24**] 10:00 PM
   Morphine Sulfate - [**2160-12-25**] 02:20 AM
   Other medications:
   Atorvastatin 80mg
   Heparin 5000u sc
   Colace 100mg [**Hospital1 7**]
   ASA 325 daily
   Plavix 75mg
   Prns:
   APAP
   Morphine Sulfate IV
   Senna
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-25**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 56 (51 - 63) bpm
   BP: 100/66(74) {88/58(62) - 109/75(81)} mmHg
   RR: 23 (11 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
             Total In:
                                                                  1,284 mL
                                                                    405 mL
   PO:
                                                                    240 mL
             TF:
   IVF:
                                                                  1,044 mL
                                                                    405 mL
   Blood products:
   Total out:
                                                                    450 mL
                                                                    325 mL
   Urine:
                                                                    450 mL
                                                                    325 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    834 mL
                                                                     80 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   163 K/uL
   13.6 g/dL
   4.5 mEq/L
   106 mEq/L
   139 mEq/L
   37.9 %
   17.1 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
   WBC
   17.1
   Hct
   37.9
   Plt
   [**Telephone/Fax (3) 3547**]
   TropT
   10.95
   8.17
   Other labs: CK / CKMB / Troponin-T:2900/204/8.17
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia. Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.
   - Start high dose ASA, plavix, high dose statin
   - Start bblocker, ACE-I as blood pressure and HR tolerates
   - Follow CE's until peak
   - Ck HgA1C for risk reduction
   - 2hr platelet ck while on integrillin
   - Post cath ck this evening
   - Morphine PRN for CP
   .
   #. Pump: No history of CHF by history or symptoms. [**Month (only) 51**] have component
   of diastolic dysfunction given history of hypertension.
   - Evaluate with ECHO
   .
   #. Rhythm: Sinus bradycardia. Hold on bblocker for now.
   - Monitor on tele
   .
   #. Borderline HTN:
   - monitor BP's on cardiac meds
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 in AM
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2160-12-24**] 10:00 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
   8 hr post cath check unremarkable.
   Allergies:
   Sulfonamides
   Unknown;
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2160-12-24**] 10:00 PM
   Morphine Sulfate - [**2160-12-25**] 02:20 AM
   Other medications:
   Atorvastatin 80mg
   Heparin 5000u sc
   Colace 100mg [**Hospital1 7**]
   ASA 325 daily
   Plavix 75mg
   Prns:
   APAP
   Morphine Sulfate IV
   Senna
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-25**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 56 (51 - 63) bpm
   BP: 100/66(74) {88/58(62) - 109/75(81)} mmHg
   RR: 23 (11 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
             Total In:
                                                                  1,284 mL
                                                                    405 mL
   PO:
                                                                    240 mL
             TF:
   IVF:
                                                                  1,044 mL
                                                                    405 mL
   Blood products:
   Total out:
                                                                    450 mL
                                                                    325 mL
   Urine:
                                                                    450 mL
                                                                    325 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    834 mL
                                                                     80 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   163 K/uL
   13.6 g/dL
   4.5 mEq/L
   106 mEq/L
   139 mEq/L
   37.9 %
   17.1 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
   WBC
   17.1
   Hct
   37.9
   Plt
   [**Telephone/Fax (3) 3547**]
   TropT
   10.95
   8.17
   Other labs: CK / CKMB / Troponin-T:2900/204/8.17
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia. Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.
   - Start high dose ASA, plavix, high dose statin
   - Start bblocker, ACE-I as blood pressure and HR tolerates
   - Follow CE's until peak
   - Ck HgA1C for risk reduction
   - 2hr platelet ck while on integrillin
   - Post cath ck this evening
   - Morphine PRN for CP
   .
   #. Pump: No history of CHF by history or symptoms. [**Month (only) 51**] have component
   of diastolic dysfunction given history of hypertension.
   - Evaluate with ECHO
   .
   #. Rhythm: Sinus bradycardia. Hold on bblocker for now.
   - Monitor on tele
   .
   #. Borderline HTN:
   - monitor BP's on cardiac meds
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 in AM
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2160-12-24**] 10:00 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 59-year-old male who presented with an inferior STEMI, found to have in-stent thrombosis and restenosis of a prior RCA stent. He was treated with stenting of the proximal RCA. The patient has a history of CAD, hypertension, and dyslipidemia. His current medications include high-dose ASA, Plavix, and high-dose statin. He is also receiving morphine for pain and is being monitored for cardiac rhythm.

Physical examination reveals a well-dressed middle-aged male who is oriented x3 and has a normal affect. His vital signs are stable, with a heart rate of 56 bpm, blood pressure of 100/66 mmHg, and oxygen saturation of 97%. His cardiac examination shows a normal sinus rhythm with a PMI located in the 5th intercostal space, midclavicular line.

Labs:

* Troponin-T: 10.95
* CK: 2900
* CKMB: 204
* Hct: 37.9%
* WBC: 17.1 K/uL
* Plt: [not specified]

Potential medical complications:

1. Cardiac complications: The patient has a history of CAD and is at risk for cardiac complications such as heart failure, arrhythmias, and cardiac arrest.
2. Bleeding complications: The patient is receiving anticoagulant therapy with heparin and Plavix, which may increase the risk of bleeding complications.
3. Infection: The patient is at risk for infection due to the invasive nature of the cardiac catheterization and the presence of central lines.
4. Renal complications: The patient's creatinine level is 1.63 mg/dL, which may indicate kidney damage or dysfunction.
5. Respiratory complications: The patient is at risk for respiratory complications such as pneumonia and respiratory failure due to the presence of central lines and the risk of aspiration.
6. Gastrointestinal complications: The patient is at risk for gastrointestinal complications such as nausea, vomiting, and diarrhea due to the presence of central lines and the risk of medication side effects.
7. Neurological complications: The patient is at risk for neurological complications such as seizures and stroke due to the presence of central lines and the risk of medication side effects.
8. Hematological complications: The patient is at risk for hematological complications such as anemia and bleeding due to the presence of central lines and the risk of medication side effects."
173304.0,283256,2160-12-25 06:38:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
   8 hr post cath check unremarkable.  Patient c/o mild CP o/n, resolved
   with Morphine, no EKG changes.
   Allergies:
   Sulfonamides
   Unknown;
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2160-12-24**] 10:00 PM
   Morphine Sulfate - [**2160-12-25**] 02:20 AM
   Other medications:
   Atorvastatin 80mg
   Heparin 5000u sc
   Colace 100mg [**Hospital1 7**]
   ASA 325 daily
   Plavix 75mg
   Prns:
   APAP
   Morphine Sulfate IV
   Senna
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-25**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 56 (51 - 63) bpm
   BP: 100/66(74) {88/58(62) - 109/75(81)} mmHg
   RR: 23 (11 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
             Total In:
                                                                  1,284 mL
                                                                    405 mL
   PO:
                                                                    240 mL
             TF:
   IVF:
                                                                  1,044 mL
                                                                    405 mL
   Blood products:
   Total out:
                                                                    450 mL
                                                                    325 mL
   Urine:
                                                                    450 mL
                                                                    325 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    834 mL
                                                                     80 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   137
                               [image002.gif]
                                     103
                               [image002.gif]
                                     15
   [image004.gif]
   106
                                                                   AGap=15
   [image005.gif]
   5.0
                               [image002.gif]
                                     24
                               [image002.gif]
                                     0.9
   [image007.gif]
   CK: 2195
   MB: 128
   MBI: 5.8
   Trop-T: 6.80
   Ca: 8.4 Mg: 2.1 P: 2.5
   89
                                                                      16.8
                                                            [image007.gif]
                                    13.3
   [image004.gif]
   156
                 [image008.gif]
   [image004.gif]
                                    36.7
   [image007.gif]
   PT: 12.3
   PTT: 26.5
   INR: 1.0
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
   WBC
   17.1
   Hct
   37.9
   Plt
   [**Telephone/Fax (3) 3547**]
   TropT
   10.95
   8.17
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin
   - Start Lisinopril 2.5mg, add BB if pressures tolerate
   - Morphine PRN for CP
   .
   #. Pump:  Patient with elevated JVP, c/w presentation.  Echo shows
   40-45% EF.
   .
   #. Rhythm: Sinus bradycardia. Hold on bblocker for now.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 if pt stable.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2160-12-24**] 10:00 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   STEMI
   24 Hour Events:
   8 hr post cath check unremarkable.  Patient c/o mild CP o/n, resolved
   with Morphine, no EKG changes.
   Allergies:
   Sulfonamides
   Unknown;
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2160-12-24**] 10:00 PM
   Morphine Sulfate - [**2160-12-25**] 02:20 AM
   Other medications:
   Atorvastatin 80mg
   Heparin 5000u sc
   Colace 100mg [**Hospital1 7**]
   ASA 325 daily
   Plavix 75mg
   Prns:
   APAP
   Morphine Sulfate IV
   Senna
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-25**] 06:29 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.7
   Tcurrent: 36.6
C (97.9
   HR: 56 (51 - 63) bpm
   BP: 100/66(74) {88/58(62) - 109/75(81)} mmHg
   RR: 23 (11 - 24) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
             Total In:
                                                                  1,284 mL
                                                                    405 mL
   PO:
                                                                    240 mL
             TF:
   IVF:
                                                                  1,044 mL
                                                                    405 mL
   Blood products:
   Total out:
                                                                    450 mL
                                                                    325 mL
   Urine:
                                                                    450 mL
                                                                    325 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    834 mL
                                                                     80 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ////
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   137
                               [image002.gif]
                                     103
                               [image002.gif]
                                     15
   [image004.gif]
   106
                                                                   AGap=15
   [image005.gif]
   5.0
                               [image002.gif]
                                     24
                               [image002.gif]
                                     0.9
   [image007.gif]
   CK: 2195
   MB: 128
   MBI: 5.8
   Trop-T: 6.80
   Ca: 8.4 Mg: 2.1 P: 2.5
   89
                                                                      16.8
                                                            [image007.gif]
                                    13.3
   [image004.gif]
   156
                 [image008.gif]
   [image004.gif]
                                    36.7
   [image007.gif]
   PT: 12.3
   PTT: 26.5
   INR: 1.0
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
   WBC
   17.1
   Hct
   37.9
   Plt
   [**Telephone/Fax (3) 3547**]
   TropT
   10.95
   8.17
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin
   - Start Lisinopril 2.5mg, add BB if pressures tolerate
   - Morphine PRN for CP
   .
   #. Pump:  Patient with elevated JVP, c/w presentation.  Echo shows
   40-45% EF.
   .
   #. Rhythm: Sinus bradycardia. Hold on bblocker for now.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 if pt stable.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2160-12-24**] 10:00 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, here is a summary of the information:

The patient is a 59-year-old male who presented with a STEMI and was found to have in-stent thrombosis and restenosis of his prior RCA stent. He underwent stenting of the proximal RCA and is currently in the ICU. His vital signs are stable, with a heart rate of 56 bpm, blood pressure of 100/66 mmHg, and oxygen saturation of 97%. His respiratory support is minimal, with no supplemental oxygen being delivered.

The patient's physical examination is notable for a supple neck with a jugular venous pressure of 8 cm, and a palpable peripheral pulse. His cardiac examination shows a normal sinus rhythm with a regular rate and rhythm. His chest is clear, with no wheezing or rhonchi. His abdomen is soft and non-tender, with no masses or bruits.

Laboratory results show elevated troponin levels, with a peak value of 6.80 ng/mL. His CK-MB level is elevated at 2195 IU/L, and his MB fraction is 5.8%. His cardiac enzymes are consistent with an acute myocardial infarction.

The patient's medication list includes aspirin, clopidogrel, atorvastatin, and heparin. He is also receiving morphine for pain control.

Potential medical complications that could arise include:

1. Ventricular arrhythmias: Given the patient's history of CAD and the presence of elevated troponin levels, there is a risk of ventricular arrhythmias, including ventricular fibrillation or ventricular tachycardia.
2. Heart failure: The patient's EF is 40-45%, which is below normal. He may be at risk for developing heart failure, especially if he experiences a significant increase in blood pressure or volume overload.
3. Infection: The patient has a central line in place, which increases his risk of developing a central line-associated bloodstream infection (CLABSI).
4. Respiratory failure: The patient's oxygen saturation is 97%, but he may be at risk for developing respiratory failure if his oxygen requirements increase or if he develops a respiratory infection.
5. Gastrointestinal bleeding: The patient is receiving anticoagulation therapy, which increases his risk of gastrointestinal bleeding, especially if he experiences a significant increase in blood pressure or if he develops a gastrointestinal ulcer.

Overall, the patient's condition is stable, but he is at risk for developing various medical complications. Close monitoring and management are necessary to prevent these complications and ensure the patient's optimal care."
173304.0,283256,2160-12-26 06:42:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2160-12-25**] 08:00 AM
   Allergies:
   Sulfonamides
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2160-12-25**] 09:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-26**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (100.9
   Tcurrent: 37.4
C (99.3
   HR: 70 (60 - 77) bpm
   BP: 106/70(79) {93/53(62) - 110/73(80)} mmHg
   RR: 22 (16 - 28) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                                                                  1,045 mL
                  PO:
                                                                    640 mL
                  TF:
   IVF:
                                                                    405 mL
   Blood products:
   Total out:
                                                                  1,375 mL
                                                                    550 mL
   Urine:
                                                                  1,375 mL
                                                                    350 mL
   NG:
   Stool:
   200 mL
   Drains:
   Balance:
                                                                   -330 mL
                                                                   -550 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 93%
   ABG: ///24/
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   180 K/uL
   14.6 g/dL
   97 mg/dL
   1.1 mg/dL
   24 mEq/L
   4.1 mEq/L
   20 mg/dL
   107 mEq/L
   142 mEq/L
   41.6 %
   17.5 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
                            [**2160-12-25**]  06:25 AM
                            [**2160-12-26**]  05:12 AM
   WBC
   17.1
   16.8
   17.5
   Hct
   37.9
   36.7
   41.6
   Plt
   [**Telephone/Fax (3) 3586**]56
   180
   Cr
   0.9
   1.1
   TropT
   10.95
   8.17
   6.80
   Glucose
   106
   97
   Other labs: PT / PTT / INR:12.8/27.2/1.1, CK / CKMB /
   Troponin-T:2195/128/6.80, Ca++:8.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin.
   - start low dose metoprolol, switch captopril to lisinopril
   .
   #. Pump:  Patient with elevated JVP, c/w RV failure presentation.  Echo
   shows 40-45% EF.
   .
   #. Rhythm: NSR with HR on low side.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.  SC Heparin
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: Call out today.
   1. IV access: Peripheral line, Date inserted: [**2160-12-24**] Order date:
   [**12-24**] @ 1019
   8. Heparin 5000 UNIT SC TID  Order date: [**12-24**] @ 1019
   2. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-24**] @ 1019
   9. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-24**] @ 1013
   3. Aspirin EC 325 mg PO DAILY  Order date: [**12-24**] @ 0934
   10. Morphine Sulfate 1-2 mg IV Q4H:PRN Pain
   Please hold for sedation or RR < 12.  Order date: [**12-24**] @ 1712
   4. Atorvastatin 80 mg PO DAILY  Order date: [**12-24**] @ 1019
   11. Senna 1 TAB PO BID:PRN  Order date: [**12-24**] @ 1019
   5. Captopril 3.125 mg PO TID
   Hold for SBP < 90  Order date: [**12-25**] @ 1326
   12. Sertraline 75 mg PO DAILY  Order date: [**12-25**] @ 1549
   6. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-24**] @ 0934
   13. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-24**] @ 1019
   7. Docusate Sodium 100 mg PO BID  Order date: [**12-24**] @ 1019
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2160-12-25**] 08:00 AM
   Allergies:
   Sulfonamides
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2160-12-25**] 09:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-26**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (100.9
   Tcurrent: 37.4
C (99.3
   HR: 70 (60 - 77) bpm
   BP: 106/70(79) {93/53(62) - 110/73(80)} mmHg
   RR: 22 (16 - 28) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                                                                  1,045 mL
                  PO:
                                                                    640 mL
                  TF:
   IVF:
                                                                    405 mL
   Blood products:
   Total out:
                                                                  1,375 mL
                                                                    550 mL
   Urine:
                                                                  1,375 mL
                                                                    350 mL
   NG:
   Stool:
   200 mL
   Drains:
   Balance:
                                                                   -330 mL
                                                                   -550 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 93%
   ABG: ///24/
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   180 K/uL
   14.6 g/dL
   97 mg/dL
   1.1 mg/dL
   24 mEq/L
   4.1 mEq/L
   20 mg/dL
   107 mEq/L
   142 mEq/L
   41.6 %
   17.5 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
                            [**2160-12-25**]  06:25 AM
                            [**2160-12-26**]  05:12 AM
   WBC
   17.1
   16.8
   17.5
   Hct
   37.9
   36.7
   41.6
   Plt
   [**Telephone/Fax (3) 3586**]56
   180
   Cr
   0.9
   1.1
   TropT
   10.95
   8.17
   6.80
   Glucose
   106
   97
   Other labs: PT / PTT / INR:12.8/27.2/1.1, CK / CKMB /
   Troponin-T:2195/128/6.80, Ca++:8.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin.
   - start low dose metoprolol, switch captopril to lisinopril
   .
   #. Pump:  Patient with elevated JVP, c/w RV failure presentation.  Echo
   shows 40-45% EF.
   .
   #. Rhythm: NSR with HR on low side.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.  SC Heparin
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: Call out today.
   1. IV access: Peripheral line, Date inserted: [**2160-12-24**] Order date:
   [**12-24**] @ 1019
   8. Heparin 5000 UNIT SC TID  Order date: [**12-24**] @ 1019
   2. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-24**] @ 1019
   9. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-24**] @ 1013
   3. Aspirin EC 325 mg PO DAILY  Order date: [**12-24**] @ 0934
   10. Morphine Sulfate 1-2 mg IV Q4H:PRN Pain
   Please hold for sedation or RR < 12.  Order date: [**12-24**] @ 1712
   4. Atorvastatin 80 mg PO DAILY  Order date: [**12-24**] @ 1019
   11. Senna 1 TAB PO BID:PRN  Order date: [**12-24**] @ 1019
   5. Captopril 3.125 mg PO TID
   Hold for SBP < 90  Order date: [**12-25**] @ 1326
   12. Sertraline 75 mg PO DAILY  Order date: [**12-25**] @ 1549
   6. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-24**] @ 0934
   13. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-24**] @ 1019
   7. Docusate Sodium 100 mg PO BID  Order date: [**12-24**] @ 1019<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, here is a summary of the patient's health progress in the ICU:

The patient is a 59-year-old male with a past medical history of coronary artery disease (CAD) who presented with inferior ST-segment elevation myocardial infarction (STEMI) due to in-stent thrombosis and restenosis of his prior RCA stent. He underwent stenting of the proximal RCA. His current condition is characterized by:

* Inferoposterolateral ischemia on EKG
* Persistent ST elevations and Q waves in II, III, and aVF
* Cardiac catheterization showing RCA disease, 40% stenosis in the left anterior descending (LAD) and left circumflex (LCX) arteries, and a myocardial bridge
* Risk factors for CAD, including borderline hypertension and dyslipidemia
* Elevated JVP, consistent with right ventricular (RV) failure
* Echocardiogram showing 40-45% ejection fraction (EF)

The patient's vital signs are stable, with a temperature of 37.4°C, heart rate of 70 beats per minute (bpm), and blood pressure of 106/70 mmHg. His respiratory rate is 22 inspirations per minute (insp/min), and his oxygen saturation is 93%. His laboratory results show:

* White blood cell count (WBC) 17.1 x 10^9/L
* Hemoglobin (Hb) 14.6 g/dL
* Platelet count (Plt) 180 x 10^9/L
* Creatinine (Cr) 0.9 mg/dL
* Troponin-T 10.95 ng/mL
* Glucose 106 mg/dL

The patient's medication regimen includes:

* Aspirin EC 325 mg PO daily
* Plavix 75 mg PO daily
* Atorvastatin 80 mg PO daily
* Metoprolol 25 mg PO every 12 hours
* Lisinopril 10 mg PO daily
* Morphine Sulfate 1-2 mg IV every 4 hours as needed
* Senna 1 tablet PO every 12 hours as needed
* Sertraline 75 mg PO daily

Potential medical complications that can arise from the patient's condition include:

* Cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia
* Right ventricular failure, which can lead to worsening cardiac function and increased risk of mortality
* Myocardial infarction, which can occur due to ongoing coronary artery disease or restenosis
* Respiratory failure, which can occur due to worsening cardiac function or pulmonary edema
* Infection, which can occur due to compromised immune function or indwelling catheters
* Bleeding complications, which can occur due to anticoagulant therapy or platelet dysfunction

The patient's family has been informed of his condition and has been instructed to contact the hospital if they have any concerns."
173304.0,283256,2160-12-26 06:42:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2160-12-25**] 08:00 AM
   Allergies:
   Sulfonamides
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2160-12-25**] 09:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-26**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (100.9
   Tcurrent: 37.4
C (99.3
   HR: 70 (60 - 77) bpm
   BP: 106/70(79) {93/53(62) - 110/73(80)} mmHg
   RR: 22 (16 - 28) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                                                                  1,045 mL
                  PO:
                                                                    640 mL
                  TF:
   IVF:
                                                                    405 mL
   Blood products:
   Total out:
                                                                  1,375 mL
                                                                    550 mL
   Urine:
                                                                  1,375 mL
                                                                    350 mL
   NG:
   Stool:
   200 mL
   Drains:
   Balance:
                                                                   -330 mL
                                                                   -550 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 93%
   ABG: ///24/
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   180 K/uL
   14.6 g/dL
   97 mg/dL
   1.1 mg/dL
   24 mEq/L
   4.1 mEq/L
   20 mg/dL
   107 mEq/L
   142 mEq/L
   41.6 %
   17.5 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
                            [**2160-12-25**]  06:25 AM
                            [**2160-12-26**]  05:12 AM
   WBC
   17.1
   16.8
   17.5
   Hct
   37.9
   36.7
   41.6
   Plt
   [**Telephone/Fax (3) 3586**]56
   180
   Cr
   0.9
   1.1
   TropT
   10.95
   8.17
   6.80
   Glucose
   106
   97
   Other labs: PT / PTT / INR:12.8/27.2/1.1, CK / CKMB /
   Troponin-T:2195/128/6.80, Ca++:8.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin, captopril.
   - start low dose metoprolol, uptitrate captopril today.
   - Morphine PRN for CP
   .
   #. Pump:  Patient with elevated JVP, c/w RV failure presentation.  Echo
   shows 40-45% EF.
   .
   #. Rhythm: NSR with HR on low side.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.  SC Heparin
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 if pt stable.
   1. IV access: Peripheral line, Date inserted: [**2160-12-24**] Order date:
   [**12-24**] @ 1019
   8. Heparin 5000 UNIT SC TID  Order date: [**12-24**] @ 1019
   2. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-24**] @ 1019
   9. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-24**] @ 1013
   3. Aspirin EC 325 mg PO DAILY  Order date: [**12-24**] @ 0934
   10. Morphine Sulfate 1-2 mg IV Q4H:PRN Pain
   Please hold for sedation or RR < 12.  Order date: [**12-24**] @ 1712
   4. Atorvastatin 80 mg PO DAILY  Order date: [**12-24**] @ 1019
   11. Senna 1 TAB PO BID:PRN  Order date: [**12-24**] @ 1019
   5. Captopril 3.125 mg PO TID
   Hold for SBP < 90  Order date: [**12-25**] @ 1326
   12. Sertraline 75 mg PO DAILY  Order date: [**12-25**] @ 1549
   6. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-24**] @ 0934
   13. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-24**] @ 1019
   7. Docusate Sodium 100 mg PO BID  Order date: [**12-24**] @ 1019
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 EKG - At [**2160-12-25**] 08:00 AM
   Allergies:
   Sulfonamides
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Morphine Sulfate - [**2160-12-25**] 09:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2160-12-26**] 06:35 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 38.3
C (100.9
   Tcurrent: 37.4
C (99.3
   HR: 70 (60 - 77) bpm
   BP: 106/70(79) {93/53(62) - 110/73(80)} mmHg
   RR: 22 (16 - 28) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
                  Total In:
                                                                  1,045 mL
                  PO:
                                                                    640 mL
                  TF:
   IVF:
                                                                    405 mL
   Blood products:
   Total out:
                                                                  1,375 mL
                                                                    550 mL
   Urine:
                                                                  1,375 mL
                                                                    350 mL
   NG:
   Stool:
   200 mL
   Drains:
   Balance:
                                                                   -330 mL
                                                                   -550 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 93%
   ABG: ///24/
   Physical Examination
   Gen: WDWN middle aged male in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no
   pallor or cyanosis of the oral mucosa. No xanthalesma.
   Neck: Supple with JVP of 8 cm.
   CV: PMI located in 5th intercostal space, midclavicular line. RR,
   normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4.
   Chest: No chest wall deformities, scoliosis or kyphosis. Resp were
   unlabored, no accessory muscle use. CTAB, no crackles, wheezes or
   rhonchi.
   Abd: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by
   palpation. No abdominial bruits.
   Ext: No c/c/e. No femoral bruits on L. Femoral sheath in place on R
   Skin: No stasis dermatitis, ulcers, scars, or xanthomas.
   Labs / Radiology
   180 K/uL
   14.6 g/dL
   97 mg/dL
   1.1 mg/dL
   24 mEq/L
   4.1 mEq/L
   20 mg/dL
   107 mEq/L
   142 mEq/L
   41.6 %
   17.5 K/uL
        [image002.jpg]
                            [**2160-12-24**]  10:49 AM
                            [**2160-12-24**]  06:26 PM
                            [**2160-12-25**]  12:18 AM
                            [**2160-12-25**]  06:25 AM
                            [**2160-12-26**]  05:12 AM
   WBC
   17.1
   16.8
   17.5
   Hct
   37.9
   36.7
   41.6
   Plt
   [**Telephone/Fax (3) 3586**]56
   180
   Cr
   0.9
   1.1
   TropT
   10.95
   8.17
   6.80
   Glucose
   106
   97
   Other labs: PT / PTT / INR:12.8/27.2/1.1, CK / CKMB /
   Troponin-T:2195/128/6.80, Ca++:8.4 mg/dL, Mg++:2.1 mg/dL, PO4:2.5 mg/dL
   Assessment and Plan
   ASSESSMENT AND PLAN:  59 yo M with PMH of CAD s/p RCA stent in '[**48**]
   presenting with inferior STEMI, found to have in stent thrombosis and
   restenosis of prior RCA stent, now s/p stent to (prox) RCA.
   .
   #. CAD: EKG consistent with inferoposterolateral ischemia.  AM EKG with
   persistent ST elevations and Q waves in II, III, AVF, Cardiac cath
   notable RCA disease s/p drug-eluting stent, 40% stenosis in LAD and LCX
   as well as a myocardial bridge.  Risk factors for CAD include
   borderline hypertension and dyslipidemia, both formerly diet
   controlled. Most recent lipid panel notable for LDL of 123.  Patient
   HR and BPs have been improving.
   - Continue ASA, plavix, high dose statin, captopril.
   - start low dose metoprolol, uptitrate captopril today.
   - Morphine PRN for CP
   .
   #. Pump:  Patient with elevated JVP, c/w RV failure presentation.  Echo
   shows 40-45% EF.
   .
   #. Rhythm: NSR with HR on low side.
   - Monitor on tele
   .
   #. Hyperlipidemia:
   - start high dose statin
   .
   #. FEN: Cardiac diet. Follow and replete electrolytes.
   .
   #. Access: PIV
   .
   #. PPx: PO diet.  SC Heparin
   .
   #. Code: Full
   .
   #. Contact: Girlfriend for 26 years, [**First Name8 (NamePattern2) 787**] [**Last Name (NamePattern1) 3548**]
               H: [**Telephone/Fax (1) 3549**]
               C: [**Telephone/Fax (1) 3550**]
   .
   #. Dispo: CCU for now; will likely call out to [**Hospital Ward Name 289**] 3 if pt stable.
   1. IV access: Peripheral line, Date inserted: [**2160-12-24**] Order date:
   [**12-24**] @ 1019
   8. Heparin 5000 UNIT SC TID  Order date: [**12-24**] @ 1019
   2. Acetaminophen 325-650 mg PO Q6H:PRN  Order date: [**12-24**] @ 1019
   9. Influenza Virus Vaccine 0.5 mL IM ASDIR
   Follow Influenza Protocol Document administration in POE   Order date:
   [**12-24**] @ 1013
   3. Aspirin EC 325 mg PO DAILY  Order date: [**12-24**] @ 0934
   10. Morphine Sulfate 1-2 mg IV Q4H:PRN Pain
   Please hold for sedation or RR < 12.  Order date: [**12-24**] @ 1712
   4. Atorvastatin 80 mg PO DAILY  Order date: [**12-24**] @ 1019
   11. Senna 1 TAB PO BID:PRN  Order date: [**12-24**] @ 1019
   5. Captopril 3.125 mg PO TID
   Hold for SBP < 90  Order date: [**12-25**] @ 1326
   12. Sertraline 75 mg PO DAILY  Order date: [**12-25**] @ 1549
   6. Clopidogrel 75 mg PO DAILY
   for the recommended duration  Order date: [**12-24**] @ 0934
   13. Sodium Chloride 0.9% Flush 3 mL IV Q8H:PRN line flush
   Peripheral line: Flush with 3 mL Normal Saline every 8 hours and PRN.
   Order date: [**12-24**] @ 1019
   7. Docusate Sodium 100 mg PO BID  Order date: [**12-24**] @ 1019<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 59-year-old male who was admitted to the ICU with a history of coronary artery disease (CAD) and presented with inferior ST-segment elevation myocardial infarction (STEMI). He had a prior RCA stent that was found to be occluded, and a new stent was placed in the proximal RCA.

The patient's current vital signs are:

* Temperature: 38.3°C (100.9°F)
* Heart rate: 70 beats per minute (bpm)
* Blood pressure: 106/70 mmHg
* Respiratory rate: 22 breaths per minute (bpm)
* Oxygen saturation: 93%
* Heart rhythm: Sinus rhythm

The patient's physical examination is unremarkable, except for a slight elevation in jugular venous pressure (JVP) and a decreased ejection fraction (EF) on echocardiogram.

The patient is receiving the following medications:

* Aspirin
* Plavix
* High-dose statin
* Captopril
* Metoprolol
* Morphine
* Senna
* Sertraline
* Clopidogrel
* Sodium chloride flush

The patient's laboratory results show:

* White blood cell count: 17.1 x 10^9/L
* Hemoglobin: 14.6 g/dL
* Platelet count: 180 x 10^9/L
* Creatinine: 0.9 mg/dL
* Troponin-T: 10.95 ng/mL
* Glucose: 106 mg/dL

The patient's assessment and plan include:

* Continue ASA, plavix, high-dose statin, and captopril
* Start low-dose metoprolol and uptitrate captopril today
* Morphine PRN for pain
* Monitor for signs of cardiac failure and RV failure
* Start high-dose statin for hyperlipidemia
* Cardiac diet and repletion of electrolytes
* PIV access and SC heparin
* PO diet and SC heparin
* Full code and contact information for the patient's girlfriend

Potential medical complications that may arise include:

* Cardiac failure
* RV failure
* Arrhythmias
* Infection
* Bleeding
* Hyperkalemia
* Hypoglycemia
* Electrolyte imbalance
* Renal failure
* Respiratory failure

It is essential to monitor the patient's condition closely and adjust the treatment plan as needed to prevent or manage these potential complications."
